Evidence map›Paper›PMID 25206854›Full record

ArticleNeural regeneration research2014

Acrylamide exposure impairs blood-cerebrospinal fluid barrier function.

Xue Yao, Licheng Yan, Lin Yao, Weijun Guan, Fanxu Zeng, Fuyuan Cao, Yanshu Zhang

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xue YaoCollege of Public Health, Hebei United University, Tangshan, Hebei Province, China.
Licheng YanCollege of Public Health, Hebei United University, Tangshan, Hebei Province, China.
Lin YaoExperimental Animal Center, Hebei United University, Tangshan, Hebei Province, China.
Weijun GuanKey Laboratory of Hebei Health and Safety on Coal Industry, Hebei United University, Tangshan, Hebei Province, China.
Fanxu ZengCollege of Public Health, Hebei United University, Tangshan, Hebei Province, China.
Fuyuan CaoExperimental Animal Center, Hebei United University, Tangshan, Hebei Province, China.
Yanshu ZhangCollege of Public Health, Hebei United University, Tangshan, Hebei Province, China.
North China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies show that chronic acrylamide exposure leads to central and peripheral neu-ropathy. However, the underlying mechanisms remained unclear. In this study, we examined the permeability of the blood-cerebrospinal fluid barrier, and its ability to secrete transthyretin and transport leptin of rats exposed to acrylamide for 7, 14, 21 or 28 days. Transthyretin levels in cerebrospinal fluid began to decline on day 7 after acrylamide exposure. The sodium fluorescein level in cerebrospinal fluid was increased on day 14 after exposure. Evans blue concentration in cerebrospinal fluid was increased and the cerebrospinal fluid/serum leptin ratio was decreased on days 21 and 28 after exposure. In comparison, the cerebrospinal fluid/serum albumin ratio was increased on day 28 after exposure. Our findings show that acrylamide exposure damages the blood-cerebrospinal fluid barrier and impairs secretory and transport functions. These changes may underlie acrylamide-induced neurotoxicity.

Indexed as

acrylamideblood-cerebrospinal fluid barrierbrain injurycerebrospinal fluidcerebrospinal fluid/serum albumin ratioleptinnerve regenerationneural regenerationNSFC grantpermeabilitythyroid hormonetight junction

Identifiers

PMID25206854
PMCPMC4153501
OpenAlexW2045079365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.